CGN Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.97M Buy
3,311
+2
+0.1% +$2.04K 0.29% 66
2026
Q1
$3.04M Buy
3,309
+216
+7% +$219K 0.24% 83
2025
Q4
$3.32M Sell
3,093
-260
-8% -$249K 0.26% 75
2025
Q3
$2.56M Sell
3,353
-157
-4% -$117K 0.21% 101
2025
Q2
$2.74M Buy
3,510
+161
+5% +$125K 0.24% 88
2025
Q1
$2.77M Sell
3,349
-850
-20% -$707K 0.27% 85
2024
Q4
$3.24M Buy
4,199
+1,040
+33% +$861K 0.32% 71
2024
Q3
$2.8M Buy
3,159
+442
+16% +$397K 0.28% 86
2024
Q2
$2.46M Buy
2,717
+1,716
+171% +$1.37M 0.29% 90
2024
Q1
$779K Buy
1,001
+14
+1% +$9.96K 0.1% 159
2023
Q4
$575K Sell
987
-310
-24% -$181K 0.08% 172
2023
Q3
$697K Buy
1,297
+501
+63% +$258K 0.09% 166
2023
Q2
$373K Sell
796
-26
-3% -$10.9K 0.05% 182
2023
Q1
$282K Hold
822
0.04% 198
2022
Q4
$301K Hold
822
0.05% 187
2022
Q3
$266K Buy
822
+59
+8% +$18.7K 0.07% 201
2022
Q2
$247K Buy
763
+18
+2% +$5.4K 0.07% 192
2022
Q1
$213K Sell
745
-38
-5% -$9.78K 0.05% 210
2021
Q4
$216K Buy
+783
New +$198K 0.06% 203
2021
Q3
Sell
-1,795
Closed -$412K 202
2021
Q2
$412K Sell
1,795
-26
-1% -$5.22K 0.13% 151
2021
Q1
$340K Buy
1,821
+62
+4% +$12.1K 0.12% 153
2020
Q4
$297K Buy
+1,759
New +$263K 0.12% 156

Other funds holding LLY